Elevated international normalized ratio in the ED: Clinical course and physician adherence to the published recommendations

American Journal of Emergency Medicine

Volumn 23, Issue 1, 2005, Pages 40-44

  Atreja, Ashish ^a   El Sameed, Yaser Abu ^a   Jneid, Hani ^b   Hoogwerf, Byron J ^a   Peacock, William Frank ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE COURSE; EMERGENCY WARD; GASTROINTESTINAL HEMORRHAGE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INTERNATIONAL NORMALIZED RATIO; LENGTH OF STAY; PATIENT SELECTION; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT;

EID: 12744258021     PISSN: 07356757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajem.2004.01.005     Document Type: Article

References (15)

1. C.S. Landefeld, and R.J. Beyth Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention Am. J. Med. 95 1993 315 328
2. The Stroke Prevention in Atrial Fibrillation Investigators Bleeding during antithrombotic therapy in patients with atrial fibrillation Arch. Intern. Med. 156 1996 409 416
3. J. Launbjerg, H. Egeblad, and J. Heaf Bleeding complications to oral anticoagulant therapy: multivariate analysis of 1010 treatment years in 551 outpatients J. Intern. Med. 229 1991 351 355
4. G. Palareti, N. Leali, and S. Coccheri Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT) Lancet 348 1996 423 428
5. F.H. Steffensen, K. Kristensen, and E. Ejlersen Major hemorrhagic complications during oral anticoagulant therapy in a Danish population-based cohort J. Intern. Med. 242 1997 497 503
6. M.N. Levine, G. Raskob, and J. Hirsh Hemorrhagic complications of long-term anticoagulant therapy Chest 89 Suppl. 1986 15S 25S
7. J. Hirsh, J. Dalen, G. Guyatt American College of Chest Physicians The Sixth ACCP recommendations for antithrombotic therapy for prevention and treatment of thrombosis. American College of Chest Physicians Chest 119 1 Suppl. 2001 1S 2S
8. J. Cruickshank, M. Ragg, and D. Eddey Warfarin toxicity in the emergency department: recommendations for management Emerg. Med. (Fremantle) 13 1 2001 91 97
9. A.S. Gallus, R.I. Baker, and B.H. Chong Consensus recommendations for warfarin therapy. Recommendations from the Australasian Society of Thrombosis and Haemostasis Med. J. Aust. 172 12 2000 600 605
10. Haemostasis and Thrombosis Task Force of the British Society for Haematology Recommendations on oral anticoagulation, 3rd ed Br. J. Haematol. 101 1998 374 387
11. M. Makris, and H.G. Watson The management of coumarin-induced over-anticoagulation. Annotation Br. J. Haematol. 114 2 2001 271 280
12. M. Makris, M. Greaves, and W.S. Phillips Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy Thromb. Haemost. 77 3 1997 477 480
13. E.N. Libby, and D.A. Garcia A survey of oral vitamin K use by anticoagulation clinics Arch. Intern. Med. 162 16 2002 1893 1896
14. G. Raj, R. Kumar, and W.P. McKinney Time course of reversal of anticoagulant effect of warfarin by intravenous and subcutaneous phytonadione [published correction appears in Arch Intern Med 2000;160(7):986] Arch. Intern. Med. 159 22 1999 2721 2724
15. J.J. Glover, and G.B. Morrill Conservative treatment of overanticoagulated patients Chest 108 4 1995 987 990